• FDA’s driver of in silico medicine, Tina Morrison, promoted to Director of Regulatory Science and Innovation at FDA

    Our long-term collaborator and in silico advocate at FDA, Tina Morrison, has been promoted to Director of Regulatory Science and Innovation
    -Read more-
  • Contribute to the new book project ‘Digital Human Modeling and the Digital Patient’

    The book, that will be published by Elsevier/Academic Press, explores the body of knowledge and state-of-the-art in Digital Human Modelling (DHM) with its application in Medicine. If you're interested to contribute the deadline for the submission of chapters is 31st March 2021.
    -Read more-
  • VPHi Success Stories

    An increasing number of digital technologies are reaching the patient, sometimes directly but more often through their physicians and through the devices/ drugs they are relying on. In this brochure the VPHi has collected a first selection of in silico medicine success stories that have brought a significant impact!
    -Read more-
  • An innovative Virtual Human Platform for Safety Assessment

    The Dutch Research Agenda has awarded 9.9 million euros to implement a new way to assess the safety of chemicals and pharmaceuticals without using laboratory animals.
    -Read more-
  • In Silico is mentioned in the Pharmaceutical Strategy for Europe

    On 25 November 2020, the European Commission adopted its Pharmaceutical strategy for Europe and we are very proud that in silico medicine and CM&S are mentioned in the document!
    -Read more-
  • Mapping the use of computer modeling & simulation in clinics

    The VPHi is excited to launch the 1st survey specifically designed for clinicians to map their level of knowledge and use of computer modeling & simulation.
    -Read more-


More news


More events

Subscribe to the VPH Institute Newsletter


Read all the newsletters of the VPH Institute